サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Global In Vitro Diagnostics (IVD) Market: Analysis By Product (Medical Devices, Reagents and Kits, Services), By Technology, Application, End User, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)

世界のインビトロ診断(IVD)市場:製品(医療機器、試薬およびキット、サービス)、技術、適用、エンドユーザー、地域、および国別分析(2019年度版):ビジネスチャンスと予測(2019-2024年)

レポート概要

世界のインビトロ診断市場は、2018年に617億ドルの価値がありました。高齢人口が世界的に増加しているため、質の高い医療が必要とされています。臨床決定の大部分は診断検査の結果に基づいているため、診断は重要な役割を果たします。これは個別化された治療を提供するのを助け、患者に特化した薬剤が投与されます。さらに、慢性および感染症に苦しむ患者数は世界的に増加しており、これは主に不健康なライフスタイル、大気および水質汚染、微生物の原因となる疾患の遺伝的修飾によってもたらされ、これにより、インビトロ診断市場の成長が加速するでしょう。

分子診断技術は、主に癌、遺伝病などの慢性疾患の患者数が多いこと、ならびに非侵襲性出生前検査により、世界的に市場成長を促進させるでしょう。また、在宅検査キットは、検査の容易さ、費用対効果、得られた検査結果の正確性のために、成長率が高くなるでしょう。製品タイプ別に見ると、試薬とキットは診断プロセスで消費されて補充する必要があるため、成長率が高くなります。また、IVD製品の開発と自動化における主要なIVD企業による投資の増加は、予測期間中の市場成長を促進させる見込みです。

■調査範囲

世界市場(実データ:2014~2018年、予測期間:2019~2024年)

  • インビトロ診断市場‐規模、成長、予測
  • 技術別分析:集中管理およびポイントオブケア、糖尿病ケア、分子診断、組織診断
  • 適用別分析:感染症、非感染症
  • エンドユーザー別分析:病院、ラボ、在宅検査、その他
  • 製品別分析:医療機器、試薬&キット、サービス

地域別分析‐北米、中南米、欧州、APAC(実データ:2014~2018年、予測期間:2019~2024年)

  • インビトロ診断市場‐規模、成長、予測
  • 技術別分析:集中管理およびポイントオブケア、糖尿病ケア、分子診断、組織診断
  • 適用別分析:感染症、非感染症
  • エンドユーザー別分析:病院、ラボ、在宅検査、その他
  • 製品別分析:医療機器、試薬&キット、サービス

国別分析‐米国、カナダ、ドイツ、イギリス、イタリア、中国、日本、インド、ブラジル、メキシコ(実データ:2014~2018年、予測期間:2019~2024年)

  • インビトロ診断市場‐規模、成長、予測
  • 技術別分析:集中管理およびポイントオブケア、糖尿病ケア、分子診断、組織診断
  • 適用別分析:感染症、非感染症
  • エンドユーザー別分析:病院、ラボ、在宅検査、その他
  • 製品別分析:医療機器、試薬&キット、サービス

その他

  • 市場勢力図
  • 主要企業
  • 主な発展
  • 市場ダイナミクス‐促進要因、抑制要因
  • 市場動向
  • SWOT分析
  • 企業分析- Roche、Sysmex、Abbott、Danaher、Siemens Healthineers、Biomerieux、Becton-Dickinson、Thermofisher Scientific、Bio-Rad、Ortho clinical Diagnostics

レポート詳細

目次

1. Report scope & Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary

2. Strategic Recommendations
2.1 Focus on Theranostics
2.2 Investment in Microbiology system automation
2.3 Reducing the cost of diagnostic test

3. Global IVD Market: Product Outlook

4. Global In Vitro Diagnostics Market: An Analysis
4.1 Market Size, By Value, Year 2014-2024

5. Global In Vitro Diagnostics Segmentation By Technology (By Value)
5.1 Competitive Scenario of In Vitro Diagnostics: By Technology
5.2 Centralised and Point of Care - Market Size and Forecast (2019-2024)
5.3 Diabetes Care - Market Size and Forecast (2019-2024)
5.4 Molecular Diagnostics - Market Size and Forecast (2019-2024)
5.5 Tissue Diagnostics - Market Size and Forecast (2019-2024)

6. Global In Vitro Diagnostics Market Segmentation By Application (By Value)
6.1 Competitive Scenario of Global In Vitro Diagnostics: By Application
6.2 Infectious Disease - Market Size and Forecast (2019-2024)
6.3 Non Infectious Disease- Market Size and Forecast (2019-2024)
7.Global In Vitro Diagnostics Segmentation By End User (By Value)
7.1 Competitive Scenario of Global In Vitro Diagnostics: By End User
7.2 Hospitals - Market Size and Forecast (2019-2024)
7.3 Laboratory - Market Size and Forecast (2019-2024)
7.4 Home Test - Market Size and Forecast (2019-2024)
7.5 Others - Market Size and Forecast (2019-2024

8. Global In Vitro Diagnostics Segmentation By Products (By Value)
8.1 Competitive Scenario of Global In Vitro Diagnostics: By Products
8.2 Medical Devices - Market Size and Forecast (2019-2024)
8.3 Reagents and Kits - Market Size and Forecast (2019-2024)
8.4 Services - Market Size and Forecast (2019-2024)

9. Global In Vitro Diagnostics: Regional Analysis
9.1 Competitive Scenario of Global In Vitro Diagnostics: By Region

10. North America In Vitro Diagnostics Market: Segmentation By Technology, Application, End User, Products (2019-2024)

10.1 North America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
10.2 North America In Vitro Diagnostics Market - Prominent Companies
10.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
10.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
10.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
10.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)

10.7 North America In Vitro Diagnostics Market: Country Analysis
10.8 Market Opportunity Chart of North America In Vitro Diagnostics Market- By Country, By Value (Year-2024)
10.9 Competitive Scenario of North America In Vitro Diagnostics : By Country
10.10 United States In Vitro Diagnostics Market: Size and Forecast (2019-2024)
10.11 United States In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
10.12 Canada In Vitro Diagnostics Market: Size and Forecast (2019-2024)
10.13 Canada In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
10.14 Rest of North America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
10.15 Rest of North America In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)

11. Latin America In Vitro Diagnostics Market: Segmentation By Technology, Application, End User, Products (2019-2024)

11.1 Latin America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
11.2 Latin America In Vitro Diagnostics Market - Prominent Companies
11.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
11.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
11.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
11.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)
11.7 Latin America In Vitro Diagnostics Market: Country Analysis
11.8 Market Opportunity Chart of Latin America In Vitro Diagnostics Market- By Country, By Value (Year-2024)

11.9 Competitive Scenario of Latin America In Vitro Diagnostics: By Country
11.10 Brazil In Vitro Diagnostics Market: Size and Forecast (2019-2024)
11.11 Brazil In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
11.12 Mexico In Vitro Diagnostics Market: Size and Forecast (2019-2024)
11.13 Mexico In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
11.14 Rest of Latin America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
11.15 Rest of Latin America In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)

12.Asia Pacific In Vitro Diagnostics Market: Segmentation By Technology, Application, End User, Products (2019-2024)

12.1 Asia Pacific In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.2 Asia Pacific In Vitro Diagnostics Market - Prominent Companies
12.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
12.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
12.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
12.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)

12.7 Asia Pacific In Vitro Diagnostics Market: Country Analysis
12.8 Market Opportunity Chart of Asia Pacific In Vitro Diagnostics Market- By Country, By Value (Year-2024)
12.9 Competitive Scenario of Asia Pacific In Vitro Diagnostics : By Country
12.10 Japan In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.11 Japan In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
12.12 China In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.13 China In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
12.14 India In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.15 India In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
12.16 Rest of Asia Pacific In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.17 Rest of Asia Pacific In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)

13. EMEA In Vitro Diagnostics Market: Segmentation By Technology, Application, End User, Products (2019-2024)

13.1 EMEA In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.2 EMEA In Vitro Diagnostics Market - Prominent Companies
13.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
13.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
13.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
13.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)
13.7 EMEA In Vitro Diagnostics Market: Country Analysis
13.8 Market Opportunity Chart of EMEA In Vitro Diagnostics Market- By Country, By Value (Year-2024)

13.9 Competitive Scenario of EMEA In Vitro Diagnostics : By Country
13.10 Germany In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.11 Germany In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
13.12 Italy In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.13 Italy In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
13.14 United Kingdom In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.15 United Kingdom In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
13.14 Rest of EMEA In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.15 Rest of EMEA In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)

14. Global In Vitro Diagnostics Market Dynamics
14.1 Global In Vitro diagnostic Market Drivers
14.2 Global In Vitro Diagnostic Market Restraints
14.3 Global In Vitro Diagnostic Market Trends

15. Market Attractiveness and Strategic Analysis

15.1 Market Attractiveness
15.1.1 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Technology (Year 2024)
15.1.2 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Application (Year 2024)
15.1.3 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By End User (Year 2024)
15.1.4 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Products (Year 2024)
15.1.5 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Region (Year 2024)

15.2 Strategic Analysis
15.2.1 New Product Development
15.2.2 Key Developments in In Vitro Diagnostics Market

16. Competitive Landscape
16.1 Market Share Analysis
16.2 Competitive Positioning (Leaders, Challengers, Followers, Niche Players)
16.3 SWOT Analysis
16.4 Porter’s Five Force Analysis

17. Company Analysis (Business Description, Financial Analysis, Business Strategy)
17.1 F .Hoffman-La Roche AG
17.2 Thermo Fisher Scientific
17.3 Sysmex
17.4 Abbott
17.5 Danaher
17.6 Siemens Healthineers
17.7 Biomerieux
17.8 Bio- Rad Laboratories
17.9 Becton Dickinson
17.10 Ortho Clinical Diagnostics

List of Figures
Figure 1: Global In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 2: Life expectancy above 65 years of age, year-2017
Figure 3: Deaths due to communicable, Maternal, Neonatal disorders and Nutritional Deficiencies(%), Year-2017
Figure 4: Global, Diabetics Incidence Rates, 2013-2017, Per 100000
Figure 5: Global Market share By technology 2018 & 2024
Figure 6: Global In Vitro Diagnostics Market- By Centralised and point of care, By Value (USD Million), 2014-2024
Figure 7: Global In Vitro Diagnostics Market- By Diabetes Care, By Value (USD Million), 2014-2024
Figure 8: Global In Vitro Diagnostics Market- By Molecular Diagnostics, By Value (USD Million), 2014-2024
Figure 9: Global In Vitro Diagnostics Market- By Tissue Diagnostics, By Value (USD Million), 2014-2024
Figure 10: Global Market Share by Application 2018 & 2024
Figure 11: Global In Vitro Diagnostics Market- By Non Infectious Disease, By Value (USD Million), 2014-2024
Figure 12: Global In Vitro Diagnostics Market- By Infectious Disease, By Value (USD Million), 2014-2024
Figure 13: Global Market Share By End User 2018 & 2024
Figure 14: Global In Vitro Diagnostics Market- By Hospitals, By Value (USD Million), 2014-2024
Figure 15: Global In Vitro Diagnostics Market- By Laboratory, By Value (USD Million), 2014-2024
Figure 16: Global In Vitro Diagnostics Market- By Home Test, By Value (USD Million), 2014-2024
Figure 17: Global In Vitro Diagnostics Market- By Others, By Value (USD Million), 2014-2024
Figure 18: Global Market Share By Products 2018 & 2024
Figure 19: Global In Vitro Diagnostics Market- By Medical Devices, By Value (USD Million), 2014-2024
Figure 20: Global In Vitro Diagnostics Market- By Reagents and Kits, By Value (USD Million), 2014-2024
Figure 21: Global In Vitro Diagnostics Market- By Services, By Value (USD Million), 2014-2024
Figure 22: Global Market Share by Region 2018 & 2024
Figure 23: North America in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 24: North America population aged 65 and above, 2013-2016 (% of total)
Figure 25: North America GDP per Capita, 2014-2017 (USD)
Figure 26: North America Healthcare Cost Per Capita, 2018 (USD)
Figure 27: North America Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 28: North America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 29: North America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 30: North America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 31: North America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 32: Market Opportunity Chart of North America In Vitro Diagnostics Market - By Country, By Value (Year-2024)
Figure 33: North America IVD, By Country, Year 2018 & 2024
Figure 34: United States In vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 35: United States population aged 65 and above, 2014- 2018(% of total)
Figure 36: United States GDP per Capita, 2013-2017 (USD) (In Trillion)
Figure 37: United States Healthcare Cost Per Capita, 2013-2017(USD)
Figure 38: United States Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 39: United States In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 40: Uniited States In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 41: United States In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 42: United States In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 43: Canada In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 44: Canada population aged 65 and above, 2014-2018 (% of total)
Figure 45: Canada GDP , 2013-2017 (USD) (In Trillion)
Figure 46: Canada Healthcare Cost Per Capita, 2013-2017 (%)
Figure 47: Canada Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 48: Canada In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 49: Canada In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 50: Canada In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 51: Canada In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 52: Rest of North America In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 53: Rest of North America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 54: Rest of North America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 55: Rest of North America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 56: Rest of North America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 57: Latin America in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 58: Latin America population aged 65 and above, 2013-2018 (% of total)
Figure 59: Latin America GDP, 2013-2017 (USD)(In Trillion)
Figure 60: Latin America Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 61: Latin America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 62: Latin America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 63: Latin America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 64: Latin America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 65: Market Opportunity Chart of Latin America In Vitro Diagnostics Market - By Country, By Value (Year-2024)
Figure 66: Latin America IVD, By Country, Year 2018 & 2024
Figure 67: Brazil In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 68: Brazil population aged 65 and above, 2014-2018(%of total)
Figure 69: Brazil GDP , 2013-2017 (USD) (In Trillion)
Figure 70: Brazil Healthcare Cost Per Capita, 2013-2016(%)(Expected)
Figure 71: Brazil Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 72: Brazil In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 73: Brazil In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 74: Brazil In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 75: Brazil In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 76: Mexico In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 77: Mexico population aged 65 and above, 2014-2018 (% of total)
Figure 78: Mexico GDP , 2013-2017 (USD) (In Trillion)
Figure 79: Mexico Healthcare Cost Per Capita, 2013-2017 (%)
Figure 80: Mexico Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 81: Mexico In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 82: Mexico In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 83: Mexico In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 84: Mexico In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 85: Rest of Latin America In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 86: Rest of Latin America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 87: Rest of Latin America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 88: Rest of Latin America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 89: Rest of Latin America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 90: Asia Pacific in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 91: Asia Pacific population aged 65 and above, 2014-2018 (% of total)
Figure 92: East Asia & Pacific GDP , 2013-2017 (USD) (In Trillion)
Figure 93: Asia Pacific Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 94: Asia Pacific In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 95: Asia Pacific In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 96: Asia Pacific In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 97: Asia Pacific In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 98: Market Opportunity Chart of Asia Pacific In Vitro Diagnostics Market - By Country, By Value (Year-2024)
Figure 99: Asia Pacific IVD, By Country, Year 2018 & 2024
Figure 100: Japan In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 101: Japan population aged 65 and above, 2014-2018 (% of total)
Figure 102: Japan GDP , 2013-2017 (USD) (In Trillion)
Figure 103: Japan Healthcare Cost Per Capita, 2013-2017 (%)
Figure 104: Japan Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 105: Japan In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 106: Japan In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 107: Japan In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 108: Japan In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 109: China In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 110: China population aged 65 and above, 2014-2018 (% of total)
Figure 111: China GDP, 2013-2017 (USD) (In Trillion)
Figure 112: China Healthcare Cost Per Capita, 2013-2016 (%)
Figure 113: China Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 114: China In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 115: China In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 116: China In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 117: China In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 118: India In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 119: India population aged 65 and above, 2014-2018 (% of total)
Figure 120: India GDP, 2013-2017 (USD) (In Trillion)
Figure 121: India Healthcare Cost Per Capita, 2013-2016 (%)
Figure 122: India Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 123: India In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 124: India In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 125: India In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 126: India In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 127: Rest of Asia Pacific In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 128: Rest of Asia Pacific In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 129: Rest of Asia Pacific In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 130: Rest of Asia Pacific In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 131: Rest of Asia Pacific In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 132: Europe, Middle East and Africa in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD
Figure 133: European Union and North Africa Middle East population aged 65 and above, 2014-2018 (% of total)
Figure 134: European Union and North Africa Middle East,GDP , 2013-2017 (USD) (In Trillion)
Figure 135: European Union and North Africa Middle East, Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 136: EMEA In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 137: EMEA In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 138: EMEA In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 139: EMEA In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 140: Market Opportunity Chart of EMEA In Vitro Diagnostics Market - By Country, By Value (Year-2024)
Figure 141: EMEA IVD, By Country, Year 2018 & 2024
Figure 142: Germany In Vitro Diagnostic Market Size By value,2014-2024(USD Million)
Figure 143: Germany population aged 65 and above,2014-2018(% of total)
Figure 144: Germany GDP,2013-2017(USD) (In Trillion)
Figure 145: Germany Healthcare cost per capita,2014-2018(%)
Figure 146: Germany death by liver cancer, 2014-2017(per 100k individuals)
Figure 147: Germany In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 148: Germany In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 149: Germany In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 150: Germany In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 151: Italy In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 152: Italy population aged 65 and above, 2014-2018 (% of total)
Figure 153: Italy GDP, 2013-2017 (USD) (In Trillion)
Figure 154: Italy Healthcare Cost Per Capita, 2014-2018 (%)
Figure 155: Italy Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 156: Italy In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 157: Italy In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 158: Italy In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 159: Italy In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 160: UK In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 161: UK population aged 65 and above, 2014-2018 (% of total)
Figure 162: UK GDP, 2013-2017 (USD) (In Trillion)
Figure 163: UK Healthcare Cost Per Capita, 2014-2018 (%)
Figure 164: UK Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 165: United Kingdom In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 166: UK In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 167: UK In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 168: UK In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 169: Rest of EMEA In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 170: Rest of EMEA In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 171: Rest of EMEA In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 172: Rest of EMEA In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 173: Rest of EMEA In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 174: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Technology (Year-2024)
Figure 175: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Application (Year-2024)
Figure 176: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By End User(Year-2024)
Figure 177: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Products (Year-2024)
Figure 178: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Region (Year-2024)
Figure 179: Competitive Positions of In Vitro Diagnostics Companies (2018)
Figure 180: F.Hoffman-La Roche, Diagnostics Sales Revenue, 2014-2018 (USD Million)
Figure 181: F.Hoffman-La Roche, Sales Revenue, By Region, In 2018 (%)
Figure 182: F.Hoffman-La Roche Net Income, Year 2014-2018 (USD MILLION)
Figure 183: F.Hoffman-La Roche, Diagnostics Division Business Area Sales Revenue, 2018 ,(USD Million)
Figure 184: F.Hoffman-La Roche , E7 Leading Emerging Market Sales Revenue, By Region, In 2018 (%)
Figure 185: Thermo Fisher Scientific, Sales Revenue, 2014-2018 (USD Million)
Figure 186: Thermo Fisher Scientific, Net Income, 2014-2018 (USD Million)
Figure 187: Thermo Fisher Scientific, Sales Revenue, By Business Segment, In 2018 (%)
Figure 188: Thermo Fisher Scientific, Sales Revenue, By Geographical Segment, In 2018 (%)
Figure 189: Sysmex, Sales Revenue, 2014-15 to 2018-2019 (USD Million)
Figure 190: Sysmex, Net Income, 2014-2018 (USD Million)
Figure 191: Sysmex, Sales Revenue, By Geographical Segment, In 2018 (%)
Figure 192: Abbott, Total Sales Revenue, 2014-2018 (USD Million)
Figure 193: Abbott, Net Income, 2014-2018 (USD Million)
Figure 194: Abbott, Sales Revenue, By Geographical Segment, In 2018 (%)
Figure 195: Abbott, Diagnostics Sales Revenue, 2014-2018 (USD Million)
Figure 196: Abbott, Diagnostics specific Business Division Sales Revenue, , In 2018 (USD Million)
Figure 197: Danaher, Total Sales Revenue, 2014-2018 (USD Million)
Figure 198: Danaher, Net Income, 2014-2018 (USD Million)
Figure 199: Danaher, Total Sales ,By Business Segments,2018 (USD Million)
Figure 200: Danaher, Sales Revenue ,Diagnostics Segment, By Geographical Segment, In 2018 (%)
Figure 201: Siemens Healthineers , Total Sales Revenue, 2017-2018 (USD Million)
Figure 202: Siemens Healthineers, Net Income, 2017-2018 (USD Million)
Figure 203: Siemens Healthineers Sales Revenue , By Geographical Segment, In 2018 (%)
Figure 204: Siemens Healthineers , Sales Revenue, By Segments,2018 (USD Million)
Figure 205: Siemens Healthineers Revenue By Segment, In 2018 (%) (in Billion)
Figure 206: Biomerieux , Total Sales Revenue, 2014-2018 (USD Million)
Figure 207: Biomerieux, Net Income, 2014-2018 (USD Million)
Figure 208: Biomerieux Sales Revenue , By Geographical Segment, In 2018 (%)
Figure 209: Biomerieux , Sales By Application, 2018 (%)
Figure 210: Bio-Rad Laboratories Sales Revenue, 2014-2018 (USD Million)
Figure 211: Bio-Rad Laboratories ,Business Segment wise sales FY- 2016-2018 ,(USD millions)
Figure 212: Bio-Rad Laboratories Sales Revenue, By Geographic Segment (%), FY2018
Figure 213: Bio-Rad, Net Income, 2014-2018 (USD Million)
Figure 214: Becton Dickinson Sales Revenue, 2013-2014 to 2017-2018 (USD Million)
Figure 215: Becton Dickinson , Total Business Segment Revenue FY- 2018 ,(USD millions)
Figure 216: Becton Dickinson Geographic Sales Revenue,2018 (USD Million)
Figure 217: Becton Dickinson, Net Income, 2014-2018 (USD Million)
Figure 218: Becton Dickinson, Life Sciences Business Segment Revenue 2018 ,(USD millions)

List Of Table
Table A: List of some FDA approved In Vitro Diagnostic Products
Table B: General IVDs for use in community settings and health facilities without laboratories
Table C: Health care facilities with clinical laboratories
Table D: Prominent In Vitro Diagnostics companies operating in North America Market
Table E: Prominent In Vitro Diagnostics companies operating in Latin America Market
Table F: Prominent In Vitro Diagnostics companies operating in Asia Pacific Market
Table G: Prominent In Vitro Diagnostics companies operating in EMEA Market
Table H: GlobalMarket share analysis of In Vitro Dignostic Companies

発刊日

2019/12/31

体裁

PDF / 270ページ

販売価格

2,400USD

発行

Azoth Analytics

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医療器具・機器

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE